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Abstract 
Background: Acetazolamide is recommended for the reduction of cerebrospinal fluid production in canine internal 
hydrocephalus. The efficacy of the drug in terms of alleviation of the clinical symptoms and the restoration of normal 
ventricular volume has not been documented. We hypothesize that acetazolamide inadequately improve clinical 
signs and has no effect on the ventricular volume. Six dogs with internal hydrocephalus underwent neurological 
examination and were examined by magnetic resonance imaging, on the day of the diagnosis, after treatment with 
acetazolamide directly before surgery, and 6 weeks after implantation of a vetriculo-peritoneal shunt due to lack of 
improvement after medical therapy with 10 mg/kg acetazolamide three times daily (TID). The ventricular volume in 
relation to the total brain volume was determined on each occasion. The changes in relative ventricular volume and 
of the neurological status were assessed and compared.
Results: McNemar’s test revealed no significant differences in clinical symptoms before and after medical treatment 
(P > 0.05). However, clinical symptoms changed significantly after surgical treatment (P = 0.001). The ventricle-brain 
ratio was not significantly changed after therapy with acetazolamide (P > 0.05); however, after subsequent shunt 
implantation, it was significantly reduced (P = 0.001).
Conclusion: Acetazolamide (10 mg/kg TID) showed no effects on clinical signs or ventricular volume in dogs with 
internal hydrocephalus. After subsequent ventriculo-peritoneal shunting, the dogs had a significantly reduced cer-
ebral ventricular volume and five out of six dogs had no abnormal findings in neurological examination.
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Background
Internal hydrocephalus is the most common congenital 
anomaly of the central nervous system in dogs [1–5]. In 
idiopathic communicating hydrocephalus, a mismatch 
between production and absorption leads to the accumu-
lation of cerebrospinal fluid (CSF), increase of intraven-
tricular pressure, and dilation of the ventricular system in 
affected animals. The underlying causes for a decreased 
absorption rate of CSF have not been identified yet [1, 
2]. Medical therapy for the lowering of high ventricular 
pressure which aims to reduce CSF production through 
the use of glucocorticoids and diuretics has been pro-
posed as a reasonable treatment option in hydrocephalic 
dogs [2–4]. The carbonic anhydrase inhibitor acetazola-
mide also has been proposed for medical treatment by 
some authors [2–4].
To objectively assess the efficacy of acetazolamide, we 
compared the development of clinical signs and ventricu-
lar volume before and after treatment with acetazolamide 
and after ventriculo-peritoneal shunting.
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Methods
Between 2000 and 2013, 59 dogs were diagnosed with idio-
pathic communicating internal hydrocephalus at the Clinic 
for Small Animals of the Department of Veterinary Clinical 
Sciences, Justus-Liebig-University, Giessen, Germany. All 
dogs underwent magnetic resonance imaging (MRI) of the 
head after owners’ approval. The dogs were sedated with 
0.1 ml/kg diazepam1 and 0.3 ml/kg propofol2 given intrave-
nously. General anaesthesia was maintained after endotra-
cheal intubation by inhalation of isoflurane in oxygen. MRI 
was performed using a 1.0 Tesla scanner3 and C3 coil. The 
diagnosis of idiopathic communicating hydrocephalus was 
based on severely dilated lateral ventricles in association 
with patency of the interventricular foramen and mesence-
phalic aqueduct. Cases were included as ‘severe hydroceph-
alus’ if signs of high pressure were present, e.g. 
periventricular oedema, dorsal dislocation of the corpus cal-
losum, and narrowing of the sulci and gyri as reported [6].
Portosystemic shunt was routinely ruled out in all dogs 
using in house ammonia and bile acid testing. CSF exami-
nation was within normal limits (<5 cells/µl, red blood 
count <1500/µl, protein <300 mg/l, specific gravity 1004–
1012, and no cytological abnormalities). From transverse, 
dorsal and sagittal T2-weighted images (T2-Turbospin 
echo, TE 120  ms, TR: 2900  ms, slice thickness 2.5  mm, 
field of view 160 × 160 mm, matrix 288 × 288), transverse 
FLAIR and transverse T1-3D fast field echo (FFE) 
sequences (TR 24.24, TE 6.9 ms, field of view 160 × 160, 
matrix 672 ×  672, slice thickness 1  mm) FFE images of 
the head were chosen for image segmentation and volume 
determination. Image processing for volume rendering 
was achieved using graphical software4. This program 
allows accurate manual image segmentation on a slice-by-
slice basis. All voxels corresponding to a single anatomical 
structure in the images are selected and assigned to the 
same value in the mask. The final mask thus contains 
information about all the selected anatomical structures 
in combination with the original data. Polygonal surface 
reconstruction algorithms allow the determination of the 
volumes of different structures in the images. MRI-based 
volume measurements of the various brain structures are 
routinely performed in veterinary medicine. The accuracy 
of the technique even for small volumes has been proven 
in veterinary neuroradiology [7, 8].
The total ventricular volume was calculated and 
expressed in relation to the volume of the brain includ-
ing cerebrum, cerebellum, and brainstem (ventricle-
brain ratio). The total ventricular volume comprised all 
1 Diazepam rationpharm, Ratiopharm GmbH, Ulm , Germany.
2 Propoflo Ahlbrecht Albrecht GmbH, Aulendorf, Germany.
3 Gyroscan Intera, Philips Medical Systems, Hamburg, Germany.
4 AMIRA®, Visual Concepts, Berlin, Germany.
ventricles including the choroid plexus. The delineation 
of both the ventricular system and the brain parenchyma 
to the spinal cord was set along a vertical line at the obex. 
The segmented brain and ventricle partitions are written 
and graphically presented by the program (Fig. 1).
After discussion of treatment options, six owners 
decided for medical management because of concerns of 
potential operation risk. The dogs were treated with 
10 mg/kg acetazolamide5 three times daily (TID). A thor-
ough clinical control of the dogs’ clinical status and reas-
sessment of the ventricular dimensions using MRI was 
recommended. Owners agreed to present the dog for a 
re-examination after 6 weeks of medical treatment. Due 
to a lack of improvement of clinical signs at reexamina-
tion, owners requested surgical therapy using a ventric-
ulo-peritoneal shunt system.6 MRI was repeated before 
surgery to reassess the status of the ventricular dilatation, 
for surgical planning, and for later assessment of ventric-
ular reconstitution.
For the ventriculo-peritoneal shunt placing every 
patient was placed in the right lateral recumbency. The 
fur on the head, cervical region, thorax and abdomen 
was removed and the skin was disinfected. After ros-
trotentorial approach a 5  mm hole was performed with 
a pneumatic drill in the skull at the level of the ectosyl-
vian or suprasylvian gyrus after careful determination of 
the implantation site in MRI. A cut with a scalpel blade 
was performed to open the dura and haemorrhage was 
eliminated with a bipolar cautery. Commercially avail-
able ventricular catheter with a stylet was placed into the 
left ventricle through the cerebral cortex. The depth and 
the angle of the insertion were determined prior to sur-
gery in MRI. Another end of the catheter was tunnelled 
beneath the masticatory muscle and subcutaneous to 
lateral cervical area and connected to the CSF port that 
enables transcutaneous CSF collection and further to the 
peritoneal catheter. Peritoneal catheter was placed in the 
peritoneal cavity caudal to the last rib and attached with 
a Chinese finger-trap suture.
The medical history and the degree of neurological 
signs before and after medical and surgical treatment 
were recorded using standardised examination protocols. 
The clinical examination was performed by a board-certi-
fied neurologist following a standardised protocol. Clini-
cal and MRI reexamination of the brain was performed 
6 weeks after surgery. The ventricle-brain ratio was again 
determined, based on the postoperative MRI.
Statistical analysis was performed using a commercial 
software package7. As the statistical distributions of the 
5 Diamox, Haupt Pharma, Wolfratshausen, Germany.
6 paediGav, Christoph Miethke GmbH und Co. KG, Potsdam, Germany.
7 Graph Pad Prism 4.0, Graph Pad Software Inc., San Diego, California.
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measured values were skewed to the right and the data 
did not show homogeneity of variance, a logarithmic 
transformation was performed at the beginning of the 
analysis. Following a one-factorial analysis of variance 
with repeated measures to test for global differences, the 
treatments were compared pairwise using the Student–
Newman–Keul’s test. Two way frequency tables were 
created and analysed with a one-sided exact McNemar 
test to compare clinical signs (present or not present) 
before and after surgical and medical treatment. P < 0.05 
was considered statistically significant.
Results
Age, breed, gender, and clinical signs before and after 
medical and surgical therapy are summarised in Table 1. 
McNemar’s test revealed no significant differences 
in clinical signs before and after medical treatment 
(P  >  0.05). However, there was significant improvement 
of the clinical signs after surgical treatment (P = 0.001). 
The ventricle-brain ratio was not significantly changed 
after therapy with acetazolamide (P  >  0.05); however, 
after subsequent shunt implantation, it was significantly 
reduced (P = 0.001).
Discussion
Medical and surgical treatment options exist for the 
reduction of intraventricular CSF pressure in dogs with 
idiopathic internal hydrocephalus [1–4]. Treatment fail-
ure with acetazolamide was reported for human infants 
and incidentally for a dog [9, 10]. As distinct informa-
tion about treatment success of acetazolamide ther-
apy is lacking, we prospectively assessed the efficacy 
of medical treatment in comparison with subsequent 
ventriculo-peritoneal shunting. We found that the ven-
tricular volume and the clinical signs of dogs with inter-
nal hydrocephalus were not sufficiently changed using 
acetazolamide 10 mg/kg TID. In contrast, the subsequent 
implantation of a ventriculo-peritoneal shunt reduced 
both ventricular volume and clinical signs in the same 
dogs with exception of the Boston terrier, in which clini-
cal signs improved, but the ventricle-brain ratio has not 
changed.
It has already been shown that the use of acetazolamide 
to reduce or improve clinical signs is ineffective in a large 
group of human infants with congenital hydrocepha-
lus [9]. Progression of clinical signs in dogs with hydro-
cephalus treated with acetazolamide was also incidentally 
reported [10]. It has been experimentally shown that 
the concentration of carbonic anhydrase in the choroid 
plexus of cats must be lowered by at least 99.95 % of its 
full activity to reduce CSF production significantly [13]. 
Having a half-life of 2 h and duration of action of 6–8 h 
[14], the full effect of carbonic anhydrase inhibition may 
not be sufficiently long-lived in the dog to constantly 
reduce CSF production. Higher doses and administration 
every 6 h might be more successful. Although the reduc-
tion of CSF production has been shown in dogs, none of 
these experimental studies measured the production for 
longer than 12  h [15, 16]. If the period of observation 
had been longer, CSF production might have returned to 
higher levels in these dogs, too.
Adaptive processes such as increased production 
of osmogenic ions from the ependyma and choroid 
plexus or the upregulation of an acetazolamide-resistant 
isozyme, which could be demonstrated in the epithelial 
cells of the rodent and human choroid plexuses [17], 
might also be an explanation for the lack of treatment 
success.
For the cases presented herein, the postoperative 
changes in ventricular volume can be attributed to the 
adjustments of the tissue to the reduced intraventricu-
lar pressure condition. In addition to the clinical course 
Fig. 1 3D models of the brain and ventricular system of dogs based on manual segmentation of the two dimensional outlines of the ventricular 
system in MR-images: a Cavalier King Charles spaniel with normal ventricular dimensions. b Boston terrier with internal hydrocephalus before and 
after (c) implantation of a ventriculo-peritoneal shunt (VPS). The cerebral parenchyma is transparent
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of the patient, reexpansion of the brain parenchyma and 
reduction of the ventricular volume serve as important 
morphological indicators for success or failure of CSF 
shunting surgery in human medicine [11]. Our findings 
match those reported from shunting procedures in chil-
dren that showed significantly decreased ventricular vol-
umes as early as the first 3 weeks after shunt implantation 
[11]. In case of Boston terrier the reason for the missing 
reduction is unclear. Reduction of pressure must not 
automatically lead to a restauration of brain parenchyma 
that might already have undergone atrophy under pres-
sure. Reduction of oedema and mild changes of ventricu-
lar volume might have been enough for improvement of 
unspecific neurological clinical signs like aimless barking 
or obtundation.
After induction of experimental hydrocephalus and 
ventriculo-peritoneal shunting in dogs, recovery of ven-
tricular size and gross configuration of the brain was 
observed mainly as a result of an increased volume of 
white matter due to regeneration of myelin sheaths [12]. 
Remyelination did not occur in chronic hydrocepha-
lus after widespread destruction of axons. Hence, early 
shunting at the age of 2–3  months was considered to 
be of the utmost importance in the prevention of per-
manent tissue damage [12]. The definite time point at 
which reduction of high intraventricular pressure no 
longer leads to tissue reconstitution has not been deter-
mined yet. However, irreversible damage to the axon of 
the white matter at the time of or during acetazolamide 
therapy is unlikely in our patients, as subsequent shunt 
implantation could successfully reduce ventricular vol-
ume in all and improve clinical signs in five out of six 
dogs. Although ventricular volume decreased in one 
dog, its visual impairment and absent menace response 
persisted. Visual deficits and blindness have been 
reported to respond poorly to ventriculo-peritoneal 
shunting in dogs and cats [5]. Processing and recogni-
tion of visual information is complex and requires full 
functional integrity of several cortical fields and their 
white matter connections. Irreversible damage to one 
or more visual structures including the optic radiation, 
primary and secondary visual cortex, and white mat-
ter pathways that connect visual cortical areas might 
be responsible for permanent visual deficits in this dog. 
This damage can remain after intraventricular pressure 
reduction and reconstitution of other parts of cerebral 
white matter.
The relatively low number of the patients in the concur-
rent study has to be considered as a major limiting factor. 
Medical treatment was performed with acetozolamide 
with the common dose of 10 mg/kg because this dose is 
recommended in text books. We may only have shown 
that a dose of 10  mg/kg is ineffective for treatment of 
internal hydrocephalus. Other doses were not tested. In 
an optimum manner two groups with two different doses 
of acetazolamide should have been tested. To assess the 
efficacy of the medical treatment the measurement of the 
CSF production would be optimal but unfortunately it is 
only possible in experimental studies. It is possible that 
CSF reduction after medical therapy occurs but not in a 
sufficient amount to have an influence on the reduction 
of the ventricle size.
Conclusion
Based on the results of this study we conclude that medi-
cal treatment with 10 mg/kg TID acetazolamide cannot 
sufficiently abolish neurological signs or reduce ventric-
ular size in dogs with idiopathic communicating inter-
nal hydrocephalus. In contrast to this subsequent shunt 
implantation reduced ventricular size and improved clin-
ical symptoms.
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